ATE264680T1 - Beta-carbolin arzneistoffprodukte - Google Patents

Beta-carbolin arzneistoffprodukte

Info

Publication number
ATE264680T1
ATE264680T1 AT00952371T AT00952371T ATE264680T1 AT E264680 T1 ATE264680 T1 AT E264680T1 AT 00952371 T AT00952371 T AT 00952371T AT 00952371 T AT00952371 T AT 00952371T AT E264680 T1 ATE264680 T1 AT E264680T1
Authority
AT
Austria
Prior art keywords
carboline
beta
medicinal products
medicinal
products
Prior art date
Application number
AT00952371T
Other languages
English (en)
Inventor
Neil R Anderson
Kerry J Hartauer
Martha A Kral
Gregory A Stephenson
Original Assignee
Lilly Icos Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22520112&utm_source=***_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE264680(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Lilly Icos Llc filed Critical Lilly Icos Llc
Application granted granted Critical
Publication of ATE264680T1 publication Critical patent/ATE264680T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/4985—Pyrazines or piperazines ortho- or peri-condensed with heterocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Reproductive Health (AREA)
  • Endocrinology (AREA)
  • Cardiology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Vascular Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Physical Or Chemical Processes And Apparatus (AREA)
AT00952371T 1999-08-03 2000-08-01 Beta-carbolin arzneistoffprodukte ATE264680T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US14704899P 1999-08-03 1999-08-03
PCT/US2000/020981 WO2001008688A2 (en) 1999-08-03 2000-08-01 Beta-carboline drug products

Publications (1)

Publication Number Publication Date
ATE264680T1 true ATE264680T1 (de) 2004-05-15

Family

ID=22520112

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00952371T ATE264680T1 (de) 1999-08-03 2000-08-01 Beta-carbolin arzneistoffprodukte

Country Status (33)

Country Link
EP (1) EP1200092B1 (de)
JP (1) JP4456788B2 (de)
KR (1) KR20020063842A (de)
CN (2) CN1377270A (de)
AR (1) AR033953A1 (de)
AT (1) ATE264680T1 (de)
AU (1) AU773666B2 (de)
BR (1) BR0012901A (de)
CA (1) CA2380087C (de)
CO (1) CO5200849A1 (de)
CZ (1) CZ300151B6 (de)
DE (1) DE60010089T2 (de)
DK (1) DK1200092T3 (de)
DZ (1) DZ3180A1 (de)
EA (1) EA004302B9 (de)
ES (1) ES2220506T3 (de)
HK (1) HK1044278B (de)
HR (1) HRP20020091B1 (de)
HU (1) HU229443B1 (de)
IL (1) IL147642A0 (de)
MX (1) MXPA02001197A (de)
MY (1) MY125428A (de)
NO (1) NO321602B1 (de)
NZ (1) NZ516613A (de)
PE (1) PE20010480A1 (de)
PL (1) PL199469B1 (de)
PT (1) PT1200092E (de)
SK (1) SK286365B6 (de)
SV (1) SV2002000137A (de)
TW (1) TWI235658B (de)
UA (1) UA71629C2 (de)
WO (1) WO2001008688A2 (de)
ZA (1) ZA200200825B (de)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EA004872B1 (ru) * 1999-08-03 2004-08-26 ЛИЛЛИ АЙКОС эЛ-эЛ-Си β-КАРБОЛИНОВЫЕ ФАРМАЦЕВТИЧЕСКИЕ КОМПОЗИЦИИ
EP2216329A1 (de) * 2004-10-28 2010-08-11 Dr. Reddy's Laboratories Ltd. Verfahren zur Herstellung von Tadalafil
PL1808164T3 (pl) * 2006-01-05 2009-06-30 Teva Pharma Sposób z granulacją na mokro do wytwarzania kompozycji farmaceutycznych aripiprazolu
DE102007028869A1 (de) * 2007-06-22 2008-12-24 Ratiopharm Gmbh Verfahren zur Herstellung eines Arzneimittels enthaltend Tadalafil
MD4009C2 (ro) * 2008-07-15 2010-08-31 Институт Химии Академии Наук Молдовы Utilizarea 1-metil-4-(N-metilaminobutil-4)-β-carbolinei în calitate de remediu antituberculos
DE102009033396A1 (de) 2009-07-16 2011-01-20 Ratiopharm Gmbh Wässrige Lösung und gelatinierte Zusammensetzung umfassend einen Phosphodiesterase-5-Inhibitor sowie diesbezügliche Verfahren und Verwendung
DE102009035211A1 (de) 2009-07-29 2011-02-17 Ratiopharm Gmbh Copräzipitate umfassend einen Phosphodiesterase-5-Inhibitor (PDE-5-Inhibitor) und einen pharmazeutisch verträglichen Trägerstoff, ihre Herstellung und Verwendung
WO2012085927A2 (en) * 2010-12-02 2012-06-28 Mylan Laboratories, Limited Tadalafil compositions
WO2012095151A1 (en) 2010-12-23 2012-07-19 Zaklady Farmaceutyczne Polpharma Sa Solid pharmaceutical dosage forms comprising tadalafil and methods of preparation thereof
WO2012107541A1 (en) 2011-02-10 2012-08-16 Synthon Bv Pharmaceutical composition comprising tadalafil and a cyclodextrin
WO2012107092A1 (en) 2011-02-10 2012-08-16 Synthon Bv Pharmaceutical composition comprising tadalafil and a cyclodextrin
WO2012107090A1 (en) 2011-02-10 2012-08-16 Synthon Bv Granulated composition comprising tadalafil and a disintegrant
JP5930686B2 (ja) * 2011-12-07 2016-06-08 株式会社トクヤマ 溶解性および安定性の向上した難溶性医薬品原体及びその製造方法
KR102268695B1 (ko) 2012-03-15 2021-06-23 메르크 파텐트 게엠베하 전자 소자
WO2014003678A1 (en) * 2012-06-28 2014-01-03 Xspray Microparticles Ab Pharmaceutical compositions comprising ambrisentan and solid dispersion particles containing tadalafil
WO2014003677A1 (en) * 2012-06-28 2014-01-03 Xspray Microparticles Ab Pharmaceutical compositions comprising solid dispersion particles containing tadalafil
CN105310984A (zh) * 2014-06-10 2016-02-10 合肥贝霓医药科技有限公司 一种pde5抑制剂的超微粉体及其制备方法
CN105611918B (zh) * 2014-06-24 2018-08-14 株式会社宇信乐宝贴剂 含有他达拉非的口腔崩解型膜制剂及其制备方法
SI3466951T1 (sl) 2014-07-23 2022-05-31 Krka, D.D., Novo Mesto Proces za pripravo zaviralca CGMP-fosfodiesteraze in oralne farmacevtske formulacije, ki obsega koprecipitate tadalafila
JP2016106139A (ja) * 2016-03-07 2016-06-16 株式会社トクヤマ 溶解性および安定性の向上した難溶性医薬品原体及びその製造方法
AU2018397436A1 (en) * 2017-12-26 2020-08-13 Ftf Pharma Private Limited Liquid oral formulations for PDE V inhibitors
PT3510997T (pt) 2018-01-10 2020-10-07 Gap S A Cápsulas de gelatina mole compreendendo uma suspensão de tadalafil
CN110638770B (zh) * 2019-10-25 2022-04-05 株洲千金药业股份有限公司 他达拉非片剂的制备方法及以该方法制得的片剂
WO2023227185A1 (en) 2022-05-27 2023-11-30 Rontis Hellas S.A. Improved pharmaceutical composition containing tadalafil and nanomilling process for the preparation thereof

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5618845A (en) * 1994-10-06 1997-04-08 Cephalon, Inc. Acetamide derivative having defined particle size
GB9511220D0 (en) * 1995-06-02 1995-07-26 Glaxo Group Ltd Solid dispersions

Also Published As

Publication number Publication date
EA200200119A1 (ru) 2002-06-27
CZ300151B6 (cs) 2009-02-25
CA2380087C (en) 2007-05-01
HK1044278A1 (en) 2002-10-18
NO321602B1 (no) 2006-06-12
NO20020531D0 (no) 2002-02-01
PT1200092E (pt) 2004-07-30
HU229443B1 (en) 2013-12-30
DZ3180A1 (fr) 2001-02-08
SK286365B6 (sk) 2008-08-05
DE60010089T2 (de) 2004-10-14
EP1200092B1 (de) 2004-04-21
AU773666B2 (en) 2004-06-03
AU6508400A (en) 2001-02-19
ZA200200825B (en) 2003-04-30
TWI235658B (en) 2005-07-11
AR033953A1 (es) 2004-01-21
WO2001008688A2 (en) 2001-02-08
MXPA02001197A (es) 2003-02-12
DK1200092T3 (da) 2004-08-16
CA2380087A1 (en) 2001-02-08
CZ2002387A3 (cs) 2002-10-16
CO5200849A1 (es) 2002-09-27
EA004302B1 (ru) 2004-02-26
JP4456788B2 (ja) 2010-04-28
KR20020063842A (ko) 2002-08-05
WO2001008688A3 (en) 2001-08-16
HRP20020091A2 (en) 2004-02-29
PL199469B1 (pl) 2008-09-30
HUP0202781A3 (en) 2003-10-28
PL353268A1 (en) 2003-11-03
HRP20020091B1 (en) 2006-02-28
CN101134019A (zh) 2008-03-05
JP2003505510A (ja) 2003-02-12
IL147642A0 (en) 2002-08-14
SV2002000137A (es) 2002-06-07
PE20010480A1 (es) 2001-05-26
HK1044278B (zh) 2004-10-08
EA004302B9 (ru) 2019-01-31
CN1377270A (zh) 2002-10-30
DE60010089D1 (de) 2004-05-27
UA71629C2 (en) 2004-12-15
ES2220506T3 (es) 2004-12-16
SK1722002A3 (en) 2002-05-09
NZ516613A (en) 2003-08-29
BR0012901A (pt) 2002-04-16
EP1200092A2 (de) 2002-05-02
HUP0202781A2 (hu) 2002-12-28
MY125428A (en) 2006-07-31
NO20020531L (no) 2002-04-03

Similar Documents

Publication Publication Date Title
ATE264680T1 (de) Beta-carbolin arzneistoffprodukte
NO20022970D0 (no) Hydrogel-drevet medikamentdoseringsform
NO20015175L (no) Farmasöytisk sammensetning
NO20020464D0 (no) Flerkomponent-farmasöytisk doseringsform
ATE411068T1 (de) Medikamentspender
FI4823U1 (fi) Muunnetulla tavalla vapauttava lääkeformulaatio
NO20020086L (no) Smaksmaskerte farmasöytiske flytende formuleringer
DK1128831T3 (da) Farmaceutisk moxifloxacinpræparat
NO20015670D0 (no) Forbedrede farmasöytiske formuleringer
NO20022606L (no) Farmasöytiske kombinasjoner
FR2802423B1 (fr) Compositions pharmaceutiques
FI4488U1 (fi) Farmaseuttinen koostumus
AR025867A1 (es) Formulacion portasdora farmaceutica
NO20016430D0 (no) Farmasöytisk kompleks
GB9909154D0 (en) Pharmaceutical formulation
NO20004816D0 (no) Ny farmasøytisk formulering
GB9926251D0 (en) Pharmaceutical formulation
SI1200092T1 (en) Beta-carboline drug products
ATA173599A (de) Pharmazeutisches produkt
FIU990118U0 (fi) Hammaslankatuote
FIU990361U0 (fi) Hammaslankatuote
GB9921396D0 (en) Pharmaceutical formulation
GB9919840D0 (en) Pharmaceutical formulation
GB9917774D0 (en) Pharmaceutical formulation
GB9917777D0 (en) Pharmaceutical formulation

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1200092

Country of ref document: EP